262 related articles for article (PubMed ID: 15031212)
21. Differential Effects of Platelets Selectively Activated by Protease-Activated Receptors on Meniscal Cells.
Xu H; Zou X; Xia P; Aboudi MAK; Chen R; Huang H
Am J Sports Med; 2020 Jan; 48(1):197-209. PubMed ID: 31765237
[TBL] [Abstract][Full Text] [Related]
22. Platelet specific promoters are insufficient to express protease activated receptor 1 (PAR1) transgene in mouse platelets.
Arachiche A; de la Fuente M; Nieman MT
PLoS One; 2014; 9(5):e97724. PubMed ID: 24830314
[TBL] [Abstract][Full Text] [Related]
23. Activation of protease-activated receptor (PAR) 1 by frog trefoil factor (TFF) 2 and PAR4 by human TFF2.
Zhang Y; Yu G; Wang Y; Xiang Y; Gao Q; Jiang P; Zhang J; Lee W; Zhang Y
Cell Mol Life Sci; 2011 Nov; 68(22):3771-80. PubMed ID: 21461878
[TBL] [Abstract][Full Text] [Related]
24. Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets.
Hamilton JR; Cornelissen I; Coughlin SR
J Thromb Haemost; 2004 Aug; 2(8):1429-35. PubMed ID: 15304051
[TBL] [Abstract][Full Text] [Related]
25. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries.
Hamilton JR; Moffatt JD; Frauman AG; Cocks TM
J Cardiovasc Pharmacol; 2001 Jul; 38(1):108-19. PubMed ID: 11444493
[TBL] [Abstract][Full Text] [Related]
26. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells.
Kataoka H; Hamilton JR; McKemy DD; Camerer E; Zheng YW; Cheng A; Griffin C; Coughlin SR
Blood; 2003 Nov; 102(9):3224-31. PubMed ID: 12869501
[TBL] [Abstract][Full Text] [Related]
27. The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets.
Nylander M; Osman A; Ramström S; Aklint E; Larsson A; Lindahl TL
Thromb Res; 2012 Apr; 129(4):e51-8. PubMed ID: 22283974
[TBL] [Abstract][Full Text] [Related]
28. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
Lee H; Sturgeon SA; Jackson SP; Hamilton JR
Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
[TBL] [Abstract][Full Text] [Related]
29. Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.
Fälker K; Haglund L; Gunnarsson P; Nylander M; Lindahl TL; Grenegård M
Biochem J; 2011 Jun; 436(2):469-80. PubMed ID: 21391917
[TBL] [Abstract][Full Text] [Related]
30. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.
Covic L; Gresser AL; Kuliopulos A
Biochemistry; 2000 May; 39(18):5458-67. PubMed ID: 10820018
[TBL] [Abstract][Full Text] [Related]
31. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V.
Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M
Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849
[TBL] [Abstract][Full Text] [Related]
32. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
33. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).
Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Blaber M; Blaber SI; Scarisbrick I; Diamandis EP; Hollenberg MD
Biol Chem; 2006 Jun; 387(6):817-24. PubMed ID: 16800746
[TBL] [Abstract][Full Text] [Related]
34. Perinatal lethality of Par4
French SL; Hamilton JR
Platelets; 2018 Mar; 29(2):196-198. PubMed ID: 28960148
[TBL] [Abstract][Full Text] [Related]
35. Activation of proteinase-activated receptors induces itch-associated response through histamine-dependent and -independent pathways in mice.
Tsujii K; Andoh T; Lee JB; Kuraishi Y
J Pharmacol Sci; 2008 Nov; 108(3):385-8. PubMed ID: 18987429
[TBL] [Abstract][Full Text] [Related]
36. A role for thrombin receptor signaling in endothelial cells during embryonic development.
Griffin CT; Srinivasan Y; Zheng YW; Huang W; Coughlin SR
Science; 2001 Aug; 293(5535):1666-70. PubMed ID: 11533492
[TBL] [Abstract][Full Text] [Related]
37. PAR2 knock-out C57Bl6 mice as a model for evaluating metastases of cancer cells: pilot in vivo study of the metastatic potential of B16 melanoma in knock-out (PAR2-/-) animals.
Matěj R; Zadinová M; Poučková P; Kukal J; Olejár T
Folia Biol (Praha); 2012; 58(2):81-6. PubMed ID: 22578959
[TBL] [Abstract][Full Text] [Related]
38. Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells.
Shimizu T; Nishihira J; Watanabe H; Abe R; Honda A; Ishibashi T; Shimizu H
J Biol Chem; 2004 Apr; 279(14):13729-37. PubMed ID: 14736878
[TBL] [Abstract][Full Text] [Related]
39. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells.
Colognato R; Slupsky JR; Jendrach M; Burysek L; Syrovets T; Simmet T
Blood; 2003 Oct; 102(7):2645-52. PubMed ID: 12805069
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms regulating Proteinase-Activated Receptors (PARs).
Chandrabalan A; Ramachandran R
FEBS J; 2021 Apr; 288(8):2697-2726. PubMed ID: 33742547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
